T HE BIOLOGIC ACTIVITY of cytokines as mediators
of host defense responses is controlled through regulated expression of cytokines, as well as their receptors. Tissue distribution of cytokine receptors and the production of soluble receptors are additional mechanisms that determine cytokine function.
Cloning of cytokine receptor genes has resulted in the identification of several receptor families that contain structurally related receptors.' The nerve growth factor receptor (NGFR)/tumor necrosis factor receptor (TNFR) family is characterized by the presence of 3 to 6 cysteine-rich motifs of approximately 40 amino acids in the extracellular d~m a i n .~.~ Members of this family include the low-affinity NGFR; TNFR-I,'.'j TNFR-II,7 CD40,' CD30,9 CD27,'" Fas/APO-1,""' 0X-40,13.14 and 4-1BB.I' These receptors recognize soluble or cell-surface bound ligands, which also form a family of structurally related proteins and mediate diverse cellular respon~es.~ TNF and NGF regulate cell proliferation and secretory functions in different cell Stimulation of cells through the TNFRI6 and Fas/APO-1 17," can induce apoptosis. CD40 is expressed on B lymphocytes and mediates T-cell-dependent B-cell maturation and Ig class s~i t c h .~~, '~ Stimulation of CD27,21,ZZ which is expressed on most peripheral blood T cells and mature thymocytes, and of the rat T-cell subset antigen OX-40 by specific antibodies increases lymphocyte proliferation. 4-1BB has recently been shown to function as an accessory signaling molecule during T-cell activationz3 and associate with the tyrosine kinase p56'ck. 24 We recently cloned the cDNA encoding ILA, a new member of the human NGFRNFR family, which is homologous to ." The present study shows that this receptor gene can be induced in lymphoid and different nonlymphoid cell types.
MATERIALS AND METHODS

Cells and cell culture. Human peripheral blood mononuclear cells (PBMC), monocytes, T, and B lymphocytes were prepared
Blood, Vol 85, No 4 (February 15). 1995: pp 1043-1052 creased transcription. Actinomycin D reduced ILA mRNA levels in activated lymphocytes 50% within 30 minutes, demonstrating a relatively short half-life of this mRNA. Analysis of nonlymphoid cells showed that I L A mRNA was not detectable in resting cells. However, in contrast to the lymphoidspecific expression of the murine ClBB gene, ILA was detected in nonlymphoid cells, including epithelial and hepatoma cells after stimulation with IL-lP. I L A was not detectable in several brain derived cell lines. The ILA cDNA encodes a 30-kD protein as demonstrated by in vitro translation, and this protein is immunoprecipitated by antisera that were raised against ILA peptides or a glutathione-S-transferase fusion protein. Flow cytometry showed expression of I L A protein on a subset of activated T or B lymphocytes. In conclusion, activation-dependent expression of I L A is found not only in T lymphocytes, but also in B lymphocytes, monocytes, and diverse nonlymphoid cell types. 0 1995 by The American Society of Hematology.
as previously described.26 Chondrocytes*' and synoviocytes** were isolated from tissues obtained from patients undergoing joint replacement or at autopsy from donors without known history of joint disease. Human thymocytes were isolated from tissue that was removed during cardiac surgery as previously described." Human T- The following cell lines were obtained from ATCC (Rockville, MD): U373, glioblastoma; SK-N-MC, neuroblastoma; Wen, retinoblastoma; HS683, glioma; HEp-2 epithelial; HepG2 hepatoma; A549, lung carcinoma; U937, promonocyte; Raji, EBV-transformed B cells; HUl78, Jurkat, and Molt4, T-cell lines.
RNA preparation and Northern blot analysis. Total RNA was isolated by the acid phenol method.30 Poly A+ RNA was prepared with PolyATract mRNA isolation system (Promega, Madison, WI).
RNA was fractionated on 1% agarose-formaldehyde gels and transferred to Hybond N membranes (Amersham, Arlington Heights, IL). Gel-purified DNA fragments were labeled with 32P by random priming and used as probes. The 1.4-kb full-length E A cDNA was used as probe.
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RNA loads on the filters were determined by control hybridizations with a full-length cyclophilin cDNA probe." In some experiments, a G3PDH cDNA fragment was used for control hybridizations. The fragment was amplified by reverse transcriptase-polymerase chain reaction (RT-PCR) using G3PDH primers described below and subcloned into pGEM3z (Promega).
Autoradiographs were scanned on a Microtek MSF-300G scanner (Microtek International Inc, Hsinchu, Taiwan) and bands were subsequently analyzed using NIH Image 1.44 software (National Institutes of Health, Bethesda, MD). Relative densities of hybridization signals were calculated in comparison to controls (unstimulated cells) for both ILA and cyclophilin hybridization signals. Calculations from ILA hybridizations were then corrected on the basis of those obtained for cyclophilin to correct for variable RNA loads. Primers used for glyceraldehyde 3-phosphate dehydrogenase (G3PDH) PCR were sense: TGG TAT CGT GGA AGG ACT CAT GAC and antisense: ATG CCA GTG AGC TTC CCG TTC AGC. They amplify a 190-bp fragment.
RT-PCR
Quunriturive PCR. A ILA deletion clone (ILA-DEL) was constructed by PCR-based mutagenesis, which resulted in a deletion of 200 bp between nucleotide positions 340 to 539.
The ILA cDNA from start to the Hue111 site at position 921 was subcloned into the EcoRl and SmaI site of pGEM7z (Promega) between the SP6 and T7 polymerase transcription start site. A fragment containing the 5' part of ILA was amplified using a SP6 primer and ILA-DELI. In a parallel reaction, the 3' ILA part was amplified with a T7 primer and ILA-DEL2. ILA-DEL2 contained at its 5' end 22 nucleotides identical to the 3' end of the S' TLA fragment. In a third PCR with the SP6 and T7 primers, the 5' and 3' ILA fragments served as templates for the generation of a ILA deletion fragment, which lacks the 200 nucleotides located between ILA-DELI and ILA-DEL2. This fragment was subcloned into the EcoRI and Hind111 sites of pGEM4z.
Serial dilutions of this deletion clone were coamplified with single stranded cDNA as described earlier. PCR products were separated on a I .3% agarose gel and stained with ethidium bromide. Pictures were taken with a Land MP4 Polaroid camera on positivehegative Polaroid film #665 (Polaroid Corp, Cambridge, MA), scanned, and evaluated as described for Northern blot analysis.
f n virro trunslution offLA prorein. In vitro translated ILA protein was prepared with the TNT coupled reticulocyte lysate system (Promega). ILA cDNA from position -139 to 1021 containing the complete ILA coding region but lacking the remaining 3' end was cloned into the EcoRIINot I site of pRc/CMV (Invitrogen, San Diego. CA). Two micrograms of two different plasmids, each with a promo-AG, ILA-BAC5' CAT TCC CGG GTC CTT GTA GTA AC, ILAtor for the T7 RNA polymerase 5' to the ILA coding region, were used as templates. A plasmid lacking a T7 promotor was used as a control. ?-cysteine was included into the reaction for detection of the in vitro translation products by autoradiography of sodium dodecy1 sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) separated proteins.
Producrion of un eukuryotic ILA-Ig fusion protein. An expression vector containing the coding region for the extracellular domain of ILA and human Ig Fc constant domains was prepared and used to transfect COS cells. Fusion protein was isolated on protein A sepharose columns from the conditioned media and shown to have the expected molecular mass on silver-stained polyacrylamide gels and Western blots. Sera from rabbits, which were immunized with this purified protein, contained antibodies that specifically recognized the ILA-Ig as determined by enzyme-linked immunosorbent assay (ELISA) and immunocytochemistry. The antisera were purified on protein A and the reactivity to human Fc was removed by absorption on human lg.
Preparurion I$ f L A antibodies. Antibodies were prepared against ILA peptides and the GST-ILA fusion protein. Several peptides were synthesized, coupled to keyhole limpet hemocyanin (KLH) and used to immunize New Zealand white rabbits. The rabbits produced antibodies to the peptides, and the antibodies were aftinity purified. Antibody to peptide ILA4
(pos 49 to 65: Pro-Pro-AsnSer-Phe-Ser-Ser-Ala-Gly-Gly-Gln-Arg-Thr-Ser-Asp-lle-Cys) and to peptide ILAS (pos 124 to 139): Thr-Phe-Asn-Asp-Gln-Lys-Arg-GlyIle-Ser-Arg-Pro-Trp-Thr-Asn-Cys) were used for the experiments described here. Rabbits were immunized with GST-ILA fusion protein. After three immunizations in biweekly intervals, the sera contained antibodies that recognized the GST-ILA fusion protein on Western blot. These antibody reactivities were not present in the preimmune sera from the same animals.
Affinity purijicution of pepride untiseru. Affinity; purification was performed by membrane affinity chromatography (MAC; Amicon, Beverly, MA) according to manufacturers' instructions. Briefly, peptides were dissolved in 0.5 mol/L NaHCO,, pH 9.0, at a concentration of 1 mgfmL. Membranes were soaked in this peptide solution. air dried for 2 hours at RT. treated with 1 mg/mL Na-borohydride in phosphate-buffered saline (PBS), pH 7.4, for 1 hour at 4°C. and rinsed with PBS. Serum was diluted 1.3 in PBS and filtered through 0.45-pm Acrodisc filters (Gelman Sciences, Ann Arbor, MI). Membranes with bound peptide were inserted in a MAC holder and washed with PBS. The diluted serum was passed over the filters. washed with PBS, and eluted with 100 mmol/L glycine and 100 mmol/L NaCl in PBS. Eluted material was concentrated and reconstituted in PBS by centrifugation through Centricon 30 (Amicon).
Immunojluorescence staining undjow cvtomety. Cells were analyzed using a FACScdn (Becton Dickinson, Mountain View. CA) and LYSIS11 software (Becton Dickinson). Laser excitation was at 488 nm (argon laser) for fluorescein isothiocyanate (FITC). A total of 4 X 10' cells were used per condition. Cells were washed three times in PBS, resuspended in 100 pL staining buffer (RPM1 1640. 3% FBS, 0.02% NaN,), and stained with affinity purified peptide ILA5 serum for 30 minutes on ice. After two washes with staining buffer. the cells were incubated with FTTC-labeled goat antirabbit IgG (1:40) (Boehringer Mannheim, Indianapolis, IN) in staining buffer for I hour on ice. After three more washes, the cells were analyzed by flow cytometry. was recovered as a hybridoma supernatant and titrated for optimal Tlymphocyte proliferation. Antibody to cell surface immunoglobulin (anti-p) was purchased from Cappel (Durham, NC). Hydropathicity analysis32 predicted a putative signal peptide (aa 1 to 17) and a 27 aa hydrophobic region, which is a potential transmembrane domain (aa 187 to 213), and flanked by charged residues. Following the 17 aa leader peptide, it contains an extracellular domain of 169 aa, a transmembrane region of 27 aa, and a short intracellular domain of 42 aa. Based on these features, ILA can be classified as a type I transmembrane protein.
RESULTS
Characterization of the
Two potential N-glycosylation sites at positions 138 and 149 are based on the presence of the NXS/T motif (with X being any amino acid except D or P). The serine at position 242 is a potential site for phosphotylation by protein kinase C. The two threonines at positions 234 and 235 are potential sites for phosphorylation by casein kinase 11. In addition,
ILA contains a potential binding site for the tyrosine kinase
The extracellular part of L A contains three cysteine-rich repeats, characteristic of members of the NGF/TNFR superfamily. The transmembrane domain is preceded by a serinethreonine-proline rich region (aa 160 to 185), and these three aa account for 50% (14 of 27 aa) of this domain. Similar domains are found in other members of the NGF/TNFR family. '3 Comparison of ILA with sequences in the NBRF database showed that it is probably the human homologue of the murine cDNA sequence 4-1BB (Fig l) (Fig 2) , while analysis of total RNA from stimulated PBMC showed only the 4.4-kb form. Studies on kinetics showed that ILA mRNA was rapidly induced by stimulation with PHA and PMA within 1.5 hours, increased to maximal levels by 8 hours, and declined to near background levels by 48 hours (not shown).
Stimulation of lymphocytes with an antibody to CD3 also induced LLA mRNA. As compared with stimulation with PHA and PMA, the effects of anti-CD3 had a slower onset but a longer duration. L A mRNA was first detected at 4 hours, reached the maximum at approximately 19 hours, and was still strongly expressed after 48 hours (Fig 3) .
Induction of ILA mRNA was dependent on protein synthesis. ILA mRNA was induced in primary T lymphocytes by treatment with PHA, PMA, and OKT3. Coincubation with the protein synthesis inhibitor cyclohexamide blocked ILA mRNA synthesis in both cases (Fig 4) .
Treatment of activated PBMC with actD, a transcriptional inhibitor, was used to determine L A mRNA stability. Cells were stimulated with PHA (1 pg/mL) and PMA (1 ng/mL,) for 4 hours before actD (5 pg/mL) was added. Cells were collected at different time points for analysis by RT-PCR. For quantitative analysis of ILA mRNA levels, a competitive PCR was performed by coamplifying cDNA with an ILA-DEL, lacking a 200-bp region. Figure SA between target and competitor products shifting from 4 to 8 X IO4 in the sample not treated with actD to 4 X IO4 and 2 X IO4 competitor molecules in the samples treated with actD for 15 and 30 minutes, respectively. To obtain a quantitative analysis of these results, negatives of the photographs were scanned and the ratios of target to competitor products were plotted against the number of competitor molecules present in the reaction (Fig SB) . The equivalence point (1:l ratio) of target to competitor products was reached at 3.2 X IO4 competitor molecules for the control, at 2.4 X IO4 competitor molecules for the 1 S-minute actD sample and at I .6 X IO4 Competitor molecules for the 30-minute actD sample. These values represent a half-life time of ILA mRNA of 30 minutes.
Normal human thymocytes were studied as a source of immature T lineage cells. They exhibited a similar time course of ILA mRNA induction as peripheral blood lymphocytes when stimulated with PHA and PMA. Stimulation with PHA or PMA alone was sufficient for ILA mRNA induction.
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ILA mRNA was not expressed in response to IL-lp (10 ng/ mL), leukemia inhibitory factor (LIF; 10 ng/mL), IFNy (500 U/mL), LPS ( 1 pg/mL) or TNFa ( (Fig 7) . In addition to PMA and IL-Io, ILA was also induced in monocytes by stimulation with LPS (not shown). ILA was also found in the human premonocytic cell line U937 and in vitro-derived macrophages after induction with IL-Ip ( I O ng/mL) and PMA (10 ng/mL) (not shown). and thus has a much wider tissue distribution than described for 4-1
To determine expression of ILA in the nervous system, several brain derived cell lines were tested for presence and inducibility of ILA. Using RT-PCR, ILA was not found in RNA from glioma (HS683) cells, resting or activated for 8 hours with IL-I(I0 U/mL) or IFNy (500 U/mL) or PMA (5 ng/mL) plus the calcium ionophore A23 187 (1 nmol/L) (not shown). Identical results were obtained for a glioblastoma and a retinoblastoma cell line (U373 and WERI, respectively) and for two neuroblastoma cell lines (SK-N-MC and Production of recombinant IL. 4 protein and immunoprecipitation with spec@ antibodies. To characterize ILA protein, rabbit antibodies were raised against ILA peptides and GST-ILA and ILA-Ig fusion proteins. For the production of recombinant ILA protein, the full-length ILA cDNA was cloned into the expression vector pRc/CMV. RNA derived from this plasmid was translated in vitro with reticulocyte lysate in the presence of "S-cysteine. As a specificity control, we also synthesized luciferase (luc) protein by in vitro trans-IMR-32).
lation. Analysis of the in vitro translation products by SDS-PAGE and autoradiography (no precipitation) shows the luciferase band at 60 kD and the ILA band at 30 kD as the most prominent bands (Fig 8) .
Aliquots of the identical in vitro translation products were precipitated with pre-and postimmune sera, generated by immunization of rabbits with the GST-ILA fusion protein or a synthetic ILA peptide. Figure 8 shows that luciferase was precipitated equally by the preimmune and immune antisera to ILA. This was due to binding of the proteins to the sepharose beads, which were used in the immunoprecipitation experiments (not shown). The antisera to GST-ILA and ILA peptide specifically precipitated the recombinant ILA protein. The low levels of ILA precipitated by the preimmune sera were also due to ILA binding to the sepharose beads.
These results suggest that the ILA cDNA encodes a protein, which is recognized by antisera, that were raised against ILA peptides or GST-ILA fusion protein. The predicted molecular mass of ILA is 28.4 k D . In vitro-translated ILA protein has an apparent mass of approximately 30 kD.
Flow cytometry analysis of I L A protein expression on primary lymphocytes. Specificity and titer of the antisera for staining of native ILA protein was determined by immunocytochemistry. COS cells transfected with the eukaryotic expression vector pRc/CMV-ILA, but not untransfected cells, showed strong and specific staining (not shown). The same antiserum was used for flow cytometric analysis of ILA protein expression on primary lymphocytes. Lymphocytes were activated with PMA (5 ng/mL), IL-2 ( I O 0 p/mL), and OKT3 (1:5,OOO) for 48 hours. Staining was performed with affinity purified antiserum to peptide ILA5 (32 pg/mL) and FITC-labeled antirabbit IgG (Boehringer Mannheim). Approximately 25% of the activated cells showed specific staining (Fig 9) .
DISCUSSION
Members of the NGFRNF receptor family are characterized by the presence of three to six cysteine-rich extracellular domains. ILA contains three cysteine-rich domains, and the second is composed of only 32 instead of the usual 41 to 44 amino acids. This domain structure is very similar in ILA and 4-IBB. Through the conservation of the cysteine-rich extracellular domains, the members of this receptor family share a common structure for ligand binding. Similar to other members of the NGFRNFR family, ILA contains a serinethreonine-proline-rich hinge region between the transmembrane domain and the cysteine-rich domains. For the 75-kD TNFR, it has been shown that this domain has an extended structure, which is likely to facilitate ligand binding to the cysteine-rich domains.." The interspecies identity for members of this receptor family is significantly higher than the identity of different members from the same species. For example, the human and murine type 1 and type 2 TNFR share 6 4 % and 62% identity, respectively.3h The identity between the human type 1 and 2 TNFR is limited to the ligand binding domain and is only 27%.' Similarly, the identity of murine to human CD27 is 65%. Its identity to 4-1 BB is 39%." The identity between 4-IBB and ILA is 59.6% Signal transduction through these receptors has only partially been characterized and diverse mechanisms appear to be used. The NGFR itself displays only low-affinity of NGF. High-affinity binding of NGF is obtained upon association with the trk oncogene product, which has tyrosine kinase activity.'* TNFR appear to use oxygen radicals, the phosphatidic acid, and the sphingomyelin pathways for intracellular signaling. The intracellular region of 4-IBB contains the consensus site for association with p56Ick originally identified in CD4 and CD8.39 This site appears to be functional as 4-IBB and ~5 6 "~ were coimmunoprecipitated with anti-4-1BB or anti-p56"' antibodies24 suggesting the possibility that 4-1BB on ligand binding might activate the tyrosine kinase ~5 6 "~. In 4-1BB. the sequence of the potential p56ICk binding site is CSCRCP (aa 239 to 244). The corresponding sequence in ILA, CSCRFP (aa 241 to 244), contains only one amino acid substitution. Site-directed mutagenesis showed that the two cysteine residues are the essential elements for association with p561ck.39 This sequence in ILA was confirmed with two independently isolated cDNAs and suggests that this potential signaling mechanism is conserved between 4-1BB and ILA. A threonine residue is present in the intracellular domains of CD40, Fas/APO-l, NGFR and TNFR. This residue has been implicated in CD40 signaling and may represent an additional conserved mechanism of signal transduction. In the intracellular part of ILA, as well as 4-1BB, there are two consecutive threonine residues which constitute a potential phosphorylation site for casein kinase IL4 ' Three different isofonns of ILA mRNA were detected in 8 kb isoforms. The smallest form at 1.8 kb is of sufficient size to contain the fulllength coding region, while the larger size of the two additional species is probably due to extended 3' untranslated regions. The difference between the 1.4-kb cDNA and the smallest transcript of 1.8 kb is probably due to priming of oligo dT on an internal A-rich region, because six independent cDNA clones of 1.4 kb were isolated.
ILA mRNA was not detected in nonactivated PBMC from more than 20 healthy donors using a sensitive PCR assay. However, ILA was rapidly inducible by PHA, PMA, and anti-CD3. Transcripts were detected early (90 minutes) after stimulation with PHAPMA. Immediate early genes as c-jtcn and clfos are inducible within 15 minutes." ILA thus appears to be an early activation gene.
A competitive PCR was performed to determine ILA mRNA stability. Fifteen and 30 minutes after addition of actD to activated PBMC, ILA mRNA decreased to 76% and 52% of control levels, respectively. Based on these values, the half-life of ILA mRNA was calculated to be approximately 30 minutes. This characterizes ILA as a highly unstable mRNA. In activated monocytes, the half-lives of the cjun and clfos transcripts, which are among the most unstable mRNAs, are 27 and 25 minutes, re~pectively.~' Following demonstration of ILA expression by activated PBMC, we analyzed whether ILA is similarly restricted to the expression in T lymphocytes as 4-IBB. The results showed that ILA can be induced in all major cellular subsets of the immune system and at early, as well as late, stages of their differentiation. Its expression in all normal lymphoid cell types tested was activation-dependent.
ILA was induced in blood monocytes in response to their major activators including LPS, IL-10, and PMA. In addition, it appeared that monocyte adherence is also a stimulus for the induction of this mRNA (unpublished observation). U937 cells representing immature monocytes and in vitro differentiated macrophages expressed ILA in response to PMA or IL-10.
B lymphocytes were isolated from peripheral blood of normal donors. In purified populations of these cells, ILA expression was induced by antibodies to cell surface Ig or PMA. EBV-transformed B-cell lines expressed ILA mRNA constitutively. Collectively, these results show that within the immune system ILA is more broadly expressed than 4-For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From 1BB. This indicates that ILA may not only function as the recipient on T lymphocytes for signals derived from other cells, but potentially serves as a molecule in mediating communication among different cell types of the immune system.
Of further significance to the role of L A in host defense responses is its expression in several nonlymphoid cell types. The analysis of tissue distribution performed in the present study clearly shows that ILA is inducible in human articular chondrocytes as one example of a normal mesenchymal cell type, as well as in hepatoma and epithelial tumor cell lines. It is of interest that ILA was not inducible in any of the different cell lines established from brain tumors, possibly indicating that ILA is not a product of neuronal cell types.
The other members of the NGF/TNFR family differ in their tissue distribution. The rat OX-40 is most restricted and only expressed by certain T-cell subsets. CD40 is mainly expressed by B lineage cells, while CD30 can be found on activated normal T and B cells, as well as on Hodgkin's lymphoma cells. CD27 has been detected on T and B lymphocytes, mature thymocytes, and some chronic B lymphocytic leukemias. In contrast to these receptors that appear to be restricted to T and B lymphocytes is the broad tissue distribution of the NGFR and the two TNFR. ILA is a member of this receptor family that has a wide tissue distribution and is, in this respect, similar to the NGF and TNF receptors.
Biochemical characterization of ILA protein was performed by in vitro translation of RNA, which was derived from the full-length ILA cDNA. The in vitro translation product had a molecular mass of 30 kD and was immunoprecipitated by antisera against GST/ILA fusion protein or ILA peptides. The predicted molecular weight of ILA is 28.4 k D , which is in agreement with the size of the in vitro translated protein.
The expression and inducibility of ILA protein on primary cells was demonstrated in lymphocytes where activation with known inducers of ILA mRNA also induced expression of ILA protein.
